• 1
    Tytgat GNJ, Axon ATR, Dixon MF, Graham DY, Lee A, Marshall BJ. Helicobacter pylori; causal agent in peptic ulcer disease? Working party report of the World Congresses of Gastroenterology. Oxford : Blackwell Scientific Publications, 1990 :36 45.
  • 2
    Tytgat GNJ, Lee A, Graham DY, Dixon MF, Rokkas T. The role of infectious agents in peptic ulcer disease. Gastroenterol Int 1993; 6: 76 89.
  • 3
    NIH Consensus Conference. Helicobacter pylori in peptic ulcer disease. NIH consensus development panel on Helicobacter pylori in peptic ulcer disease. J Am Med Assoc 1994; 272: 65 9.
  • 4
    Veldhuyzen van Zanten SJO & Sherman PM. Helicobacter pylori infection as the cause of gastritis, duodenal ulcer, gastric cancer and non-ulcer dyspepsia: a systematic overview. Can Med Assoc J 1994; 150: 177 85.
  • 5
    Unge P, Gad A, Eriksson K, et al. Amoxicillin added to omeprazole prevents relapse in the treatment of duodenal ulcer patients. Eur J Gastroenterol Hepatol 1993; 5: 325 31.
  • 6
    Axon ATR, O'Morain CA, Bardhan KD, et al. Randomised double blind controlled study of recurrence of gastric ulcer after treatment for eradication of Helicobacter pylori infection. Br Med J 1997; 314: 565 8.
  • 7
    Bayerdörffer E, Miehlke S, Mannes GA, et al. Double-blind trial of omeprazole and amoxycillin to cure Helicobacter pylori infection in patients with duodenal ulcers. Gastroenterol 1995; 108: 1412 17.
  • 8
    European Helicobacter pylori Study Group . Current European concepts in the management of Helicobacter pylori infection, The Maastricht consensus report. Gut 1997; 41: 8 13.
  • 9
    Hunt R & Thomson ABR, and the Consensus Conference Participants. Canadian Helicobacter pylori Consensus Conference. Can J Gastroenterol 1998; 12(1): 31 41.
  • 10
    Soll A. Medical treatment of peptic ulcer disease. Practice Guidelines. J Am Med Assoc 1996; 8: 622 9.
  • 11
    Lind T, Veldhuyzen van Zanten S, Unge P, et al. Eradication of Helicobacter pylori using one-week triple therapies combining omeprazole with two antimicrobials: the MACH 1 study. Helicobacter 1996; 1: 138 44.
  • 12
    Price AB. The Sydney System: Histological division. J Gastroenterol Hepatol 1991; 6: 209 22.
  • 13
    Lind T, Bardhan KD, Bayerdörffer E, et al. The MACH 2 study: Optimal Helicobacter pylori therapy needs omeprazole and can be reliably assessed by UBT. Gastroenterol 1997; 112: A508A508(Abstract).
  • 14
    Malfertheiner P, Bayerdörffer E, Diete U, et al. The GU-Mach study: Eradication of Helicobacter pylori, ulcer healing and relapse in gastric ulcer patients. Omeprazole and clarithromycin in combination with either amoxicillin or metronidazole . Gut 1997; 41(Suppl. 1): A97A97(Abstract).
  • 15
    Fallone C, Loo VG, Barkun AN, De Souza E, Lavallee J, Wickham C. Rate of Helicobacter pylori resistance to metronidazole, clarithromycin and six other agents. Can J Gastroenterol 1996; 10(Suppl. A): 30A30A.
  • 16
    Veldhuyzen van ZantenS, HuntRH, Cockeram A, SchepG, MalatjalianD, SidorovJ, MatiskoA, JewellD. Adding once-daily omeprazole 20 mg to metronidazole/amoxicillin treatment for Helicobacter pylori gastritis: a randomized, double-blind trial showing the importance of metronidazole resistance. Am J Gastroenterol 1998; 9393.
  • 17
    Unge P. What other regimens are under investigation to treat Helicobacter pylori infection? Gastroenterol 1997; 6(Suppl.): S131 S148.
  • 18
    Mégraud F. Resistance of Helicobacter pylori to antibiotics. Aliment Pharmacol Ther 1997; 11(Suppl. 1): 43 53.
  • 19
    Best LM, Haldane DJM, Besanson G, Velduyzen van Zanten S. Helicobacter pylori: Primary susceptibility to clarithromycin in vitro in Nova Scotia. Can J Gastroenterol 1997; 4: 298 300.
  • 20
    Veldhuyzen van Zanten S, Leung V, O'Rourke J, Lee A. The gastric transitional zones are areas where Helicobacter treatment fails. Results of a treatment trial using the sydney strain. Gastroenterol , 1998 :114(2): A301A301(Abstract).
  • 21
    Graham D, Lew GM, Evans DG, Evans DJ, Klein PD. Effect of triple therapy (antibiotics plus bismuth) on duodenal ulcer healing. Ann Int Med 1991; 115: 266 9.
  • 22
    Van Der Ende A, Van Der Hulst RMW, Dankert J, Tytgat GNJ. Reinfection versus recrudesence in Helicobacter pylori infection. Aliment Pharmacol Ther 1997; 11(Suppl. 1): 55 61.